Vensana Capital
Growth equityEdina · Series A–Late Stage
Investment thesis
Vensana Capital seeks to partner with experienced and bold management teams in the medical technology sector to drive breakthrough healthcare innovation. The firm invests across development and commercial-stage companies in medical devices, diagnostics, data science, drug delivery, digital health, life science tools, and tech-enabled services.
Source: firm website, verified Jul 21, 2026.
Investments · 1 tracked
founders shown can be your intro pathDeveloping innovative neuromodulation therapy to treat unmet clinical needs impacting large patient populations.
Board seats · per SEC filings
what is this? ⓘ$106.3M raise · filed Dec 2024 · via Peter Justin Klein
Inferred from directors named on each company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Vensana Capital invest at?
- Vensana Capital invests at the Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Vensana Capital focus on?
- Vensana Capital focuses on Digital Health, Medical Devices.
- Where is Vensana Capital located?
- Vensana Capital is headquartered in Edina, US.
Images
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
EQT Life Sciences is one of Europe's largest and most experienced life sciences investors, focusing on innovative companies developing therapeutics, medical devices, diagnostics, and healthtech globally. The firm has raised approximately 3.5 billion euros across 12 private funds and 3 investment strategies over its 30-year history.
A European investment firm established in 2016 by former Index Ventures life sciences professionals with over 20 years of experience in drug discovery and therapeutic development for unmet medical needs.